Article

Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional Genomics

2026-01-22

Abstract excerpt

Parkinson’s disease (PD) is a progressive neurodegenerative disorder lacking disease-modifying therapies, and its clinical management is limited by the absence of accessible biomarkers for tracking disease progression and treatment response. To map these complex disease trajectories, we implemented an ultra-deep plasma proteomics workflow integrating Mag-Net extracellular vesicle enrichment with Orbitrap Astral ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8bd9dae3-cbcb-5d41-b0a6-b96e49115c7e
DOI: 10.64898/2026.01.19.699565

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional GenomicsDOI 10.64898/2026.01.19.699565Read

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity Read

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseSemantic proximity Read

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingSemantic proximity Read

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiologySemantic proximity Read

Orthogonal validation of PD Biomarkers: Multi-platform proteomics profiling of CSF, Plasma, and Urine confirms DDC as a consistent candidateSemantic proximity Read

Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysisSemantic proximity Read

A proteogenomic view of Parkinson’s disease causality and heterogeneitySemantic proximity Read

Plasma acellular transcriptome contains Parkinson’s disease signatures that can inform clinical diagnosisSemantic proximity Read

Plasma Proteomics for Parkinson’s Disease: Diagnostic Classification, Severity Association, and Therapeutic HypothesesSemantic proximity Read

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read

Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseSemantic proximity Read

Urinary proteome profiling for stratifying patients with familial Parkinson's disease.Semantic proximity Read